NICE guidance on panobinostat for patients with multiple myeloma after at least two previous treatments

Caroline J Hall, Sally Doss, Nicola Hay, Frances Sutcliffe, Andrew Stevens

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)279-80
Number of pages2
JournalThe Lancet Oncology
Volume17
Issue number3
Early online date27 Jan 2016
DOIs
Publication statusPublished - Mar 2016

Keywords

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols
  • Bortezomib
  • Dexamethasone
  • Disease-Free Survival
  • Female
  • Humans
  • Hydroxamic Acids
  • Indoles
  • Male
  • Middle Aged
  • Multiple Myeloma
  • Neoplasm Invasiveness
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Practice Guidelines as Topic
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Retreatment
  • Risk Assessment
  • Survival Analysis
  • Treatment Outcome
  • United Kingdom
  • News

Cite this